Media Release : Winners of the 5th BioPharma Asia Industry Awards

10 organisations and individuals were recognised for their significant contributions on 24 March, at the 5th BioPharma Industry Awards Gala Dinner, held in conjunction with the 8th BioPharma Asia Convention 2015. The award winners are as follows. Outsourcing Category Best Contract Research Organisation — PRA Health Sciences Best Contract Manufacturing Organisation — Kemwell BioPharma, India Logistics Category Best Cold Chain …

Advanced Diagnostics takes centre stage at BioPharma Asia Convention 2015

With the progression of the biologics market globally, much is in store for the diagnostics business – particularly in technology that involves both the quality assurance, clinical research and biologics process development spheres. Enter the “Advanced Diagnostics Forum”, hosted by the Japan Analytical Instruments Manufacturers’ Association (JAIMA) and held concurrently with the onfloor seminar proceedings of the BioPharma Asia Convention …

Download White Paper : Translating Cancer Genomics for personalized approach to treating cancer

Over the past few decades, the approach to prevention, diagnosis and treatment of cancer has radically shifted from organ-based to morphology-based and most recently, to genetics-based. Personalized or precision medicine (tailoring a treatment for a patient’s particular disease at a precise time point) is being performed every day at different levels in the clinical setting.The study of cancer genomics has …

TotalBioPharma LIVE with BioSingapore

Q : “How many biotechs are there in Singapore?” A : “There are around 200 biotechs but if you are talking about the successful ones, there are only a handful.” This was one of many candid answers given by the expert panel made up of Singapore’s leading minds in the biopharmaceutical sector at the TotalBioPharma Live in Singapore meetup yesterday, …

Singapore, meetup

Biomedical Sciences industry in Singapore: Landscape & Trends

The Biomedical Sciences (BMS) industry was identified as the fourth pillar of Singapore’s economy in 2000. To date, Singapore has become a hub in Asia for cutting research in BMS as well as for development of biotechnology & medical technology products. The manufacturing of pharmaceuticals, biotechnology & medical technology products by more than 100 companies exceed S$30 billion each year; …

Roche, Meiji & Fedora next in line to combat superbugs with antibiotics booster

Roche makes its next move in antibiotic research with its licensing deal with Meiji Seika Pharma and Canada’s Fedora. The deal, worth up to $750 million, allows Roche the right to develop and commercialize beta-lactamase inhibitor OP0595 internationally, with exception to Japan. Meiji gets to keep its sole rights. Beta-lactamase inhibitors restore or potentiate the activity of beta-lactam antibiotics. The …

Download White Paper – Fed-Batch Cell Culture Process Development

CHO cell lines usually adopt the Fed-Batch approach as a primary method to manufacture therapeutic recombinant protein products. Process development for this method has been usually on how best to support high-cell density cultures that are necessary to achieve high product titres production. The issue however has always been the high nutritional demands required. If there is a lack of …

Download Presentation: Adult Adherent Stem Cells for Treatment of CNS Injury and Disease

At the last BioPharma Asia in 2013, Robert Deans of Athersys  gave the following presentation entitled: Adult Adherent Stem Cells for Treatment of CNS Injury and Disease. Click here to download this presentation. In this presentation, he covered topics on: Overview of MultiStem in phase II clinical development as well as in enhancing healing. Developmental and biodistribution hurdles of Multistem …